Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Multiprofessional Hospital For Active Treatment Iulia Vrevska-Byala EOOD

Bulgaria Ulitsa Vasil Levski 62, 7100 Byala, Bulgaria

  • 1 trial recruiting
  • Hypertriglyceridaemia · Chronic kidney disease · Hypertension
  • Adult patients

About Specializations

Multiprofessional Hospital For Active Treatment Iulia Vrevska-Byala EOOD in Byala, Bulgaria specialises in clinical trials of conditions such as Hypertriglyceridaemia, Chronic kidney disease, Hypertension, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Endocrinology and Metabolic Disorders

The medical center is at the forefront of research in Endocrinology, focusing on innovative treatments for Type 2 Diabetes. The center's research aims to improve the management of diabetes, particularly in patients who are inadequately controlled with existing therapies.

  • Type 2 Diabetes Management
  • Combination Therapies
  • Glycemic Control

By exploring the efficacy of combining gliclazide MR with dapagliflozin and potentially metformin, the center contributes to the development of more effective treatment regimens, aiming to reduce HbA1c levels and enhance patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Vasil Levski 627100 ByalaBulgaria
Open in maps ↗
Recruiting now
1 trial
Conditions studied
5

More sites in ByalaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Chronic kidney disease+1

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Obesity

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Type 2 diabetes mellitus

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Institut De Recherches Internationales Servier IRIS
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.